Agilent Technologies, Inc. $A Shares Bought by Bank of New York Mellon Corp

Key Points

• Bank of New York Mellon increased its Agilent Technologies stake by 87.4% in the second quarter, buying 2.44 million additional shares. It now owns 5.23 million shares, or 1.85% of the company, valued at approximately $695.2 million.
• Agilent reported quarterly earnings of $1.49 per share, exceeding estimates of $1.41, while revenue rose 10% year over year to $1.83 billion. The company guided to fiscal 2026 earnings of $6.00–$6.10 per share.
• Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and a $160.24 price target. Agilent shares recently opened at $156.50, near their 52-week high of $160.27.

Bank of New York Mellon Corp raised its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 87.4% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,233,964 shares of the medical research company's stock after purchasing an additional 2,440,360 shares during the quarter. Bank of New York Mellon Corp owned 1.85% of Agilent Technologies worth $695,227,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. SHP Wealth Management purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $26,000. Core Wealth Advisors LLC purchased a new position in shares of Agilent Technologies during the fourth quarter worth $26,000. Navalign LLC acquired a new position in Agilent Technologies during the fourth quarter valued at $27,000. MV Capital Management Inc. acquired a new position in Agilent Technologies during the fourth quarter valued at $28,000. Finally, Entrust Financial LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at $31,000.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $156.50 on Friday. The stock has a market capitalization of $44.20 billion, a P/E ratio of 31.43, a P/E/G ratio of 2.75 and a beta of 1.25. The company's fifty day moving average price is $136.98 and its 200 day moving average price is $126.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The firm's revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A has been the topic of several analyst reports. Barclays increased their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 24th. Robert W. Baird boosted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a report on Tuesday, May 26th. Sanford C. Bernstein began coverage on Agilent Technologies in a research note on Friday, June 26th. They issued an "outperform" rating and a $155.00 target price on the stock. HSBC dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Finally, Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source